Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review
dc.contributor.author | Sabir, Fakhara | |
dc.contributor.author | Qindeel, Maimoona | |
dc.contributor.author | Zeeshan, Mahira | |
dc.contributor.author | Ul Ain, Qurrat | |
dc.contributor.author | Rahdar, Abbas | |
dc.contributor.author | Barani, Mahmood | |
dc.contributor.author | González, Edurne | |
dc.contributor.author | Aboudzadeh, Ali ![]() | |
dc.date.accessioned | 2021-04-30T12:13:39Z | |
dc.date.available | 2021-04-30T12:13:39Z | |
dc.date.issued | 2021-04-01 | |
dc.identifier | doi: 10.3390/pr9040621 | |
dc.identifier.citation | Processes 9(4) : (2021) // Article ID 621 | es_ES |
dc.identifier.issn | 2227-9717 | |
dc.identifier.uri | http://hdl.handle.net/10810/51270 | |
dc.description.abstract | Lung cancer is among the most prevalent and leading causes of death worldwide. The major reason for high mortality is the late diagnosis of the disease, and in most cases, lung cancer is diagnosed at fourth stage in which the cancer has metastasized to almost all vital organs. The other reason for higher mortality is the uptake of the chemotherapeutic agents by the healthy cells, which in turn increases the chances of cytotoxicity to the healthy body cells. The complex pathophysiology of lung cancer provides various pathways to target the cancerous cells. In this regard, upregulated onco-receptors on the cell surface of tumor including epidermal growth factor receptor (EGFR), integrins, transferrin receptor (TFR), folate receptor (FR), cluster of differentiation 44 (CD44) receptor, etc. could be exploited for the inhibition of pathways and tumor-specific drug targeting. Further, cancer borne immunological targets like T-lymphocytes, myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), and dendritic cells could serve as a target site to modulate tumor activity through targeting various surface-expressed receptors or interfering with immune cell-specific pathways. Hence, novel approaches are required for both the diagnosis and treatment of lung cancers. In this context, several researchers have employed various targeted delivery approaches to overcome the problems allied with the conventional diagnosis of and therapy methods used against lung cancer. Nanoparticles are cell nonspecific in biological systems, and may cause unwanted deleterious effects in the body. Therefore, nanodrug delivery systems (NDDSs) need further advancement to overcome the problem of toxicity in the treatment of lung cancer. Moreover, the route of nanomedicines’ delivery to lungs plays a vital role in localizing the drug concentration to target the lung cancer. Surface-modified nanoparticles and hybrid nanoparticles have a wide range of applications in the field of theranostics. This cross-disciplinary review summarizes the current knowledge of the pathways implicated in the different classes of lung cancer with an emphasis on the clinical implications of the increasing number of actionable molecular targets. Furthermore, it focuses specifically on the significance and emerging role of surface functionalized and hybrid nanomaterials as drug delivery systems through citing recent examples targeted at lung cancer treatment. | es_ES |
dc.description.sponsorship | The APC was funded through PHOTO-EMULSION project. Financing entity: European Union H2020-MSCA-ITN-2017. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.relation | info:eu-repo/grantAgreement/EC/H2020/765341 | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | |
dc.subject | lung cancer | es_ES |
dc.subject | nanoparticles | es_ES |
dc.subject | toxicity | es_ES |
dc.subject | surface modification | es_ES |
dc.subject | hybrid nanocarriers | es_ES |
dc.title | Onco-Receptors Targeting in Lung Cancer via Application of Surface-Modified and Hybrid Nanoparticles: A Cross-Disciplinary Review | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.date.updated | 2021-04-23T13:32:37Z | |
dc.rights.holder | 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). | es_ES |
dc.relation.publisherversion | https://www.mdpi.com/2227-9717/9/4/621/htm | es_ES |
dc.identifier.doi | 10.3390/pr9040621 | |
dc.departamentoes | Química aplicada | |
dc.departamentoeu | Kimika aplikatua |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).